NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension.

Proceedings of the National Academy of Sciences of the United States of America2001Fiorucci S, Antonelli E, Morelli O, et al.

Study designOther primary literature

SubjectAnimal

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AnimalsCarbon TetrachlorideCollagenHypertension, PortalLiverLiver CirrhosisMaleNitratesNitric OxideNitric Oxide DonorsRatsRats, WistarSalicylatesUrsodeoxycholic Acid

DOI 10.1073/pnas.151136298

PMID 11447266

View source →